Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
about
miR-155 as a Biomarker in B-Cell MalignanciesHepatitis C virus-associated B-cell non-Hodgkin's lymphomas: what do we know?MicroRNA expression in hepatitis C virus-related malignancies: A brief reviewDirect effects of hepatitis C virus on the lymphoid cellsMicroRNAs, Major Players in B Cells Homeostasis and FunctionMicroRNAs, hepatitis C virus, and HCV/HIV-1 co-infection: new insights in pathogenesis and therapyAntiviral therapy of hepatitis C as curative treatment of indolent B-cell lymphomaVasculitic syndromes in hepatitis C virus: A review.microRNA levels in paraffin-embedded indolent B-cell non-Hodgkin lymphoma tissues from patients chronically infected with hepatitis B or C virusComplex interactions between microRNAs and hepatitis B/C viruses.An integrated genomic and expression analysis of 7q deletion in splenic marginal zone lymphomaRole of microRNA profile modifications in hepatitis C virus-related mixed cryoglobulinemiaB-cell-intrinsic hepatitis C virus expression leads to B-cell-lymphomagenesis and induction of NF-κB signalling.Molecular signature in HCV-positive lymphomasWhole exome sequencing of microdissected splenic marginal zone lymphoma: a study to discover novel tumor-specific mutations.The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection.miR-2861 acts as a tumor suppressor via targeting EGFR/AKT2/CCND1 pathway in cervical cancer induced by human papillomavirus virus 16 E6Towards incorporating epigenetic mechanisms into carcinogen identification and evaluation.Hepatitis C virus-related mixed cryoglobulinemia: is genetics to blame?New insights into HCV-related rheumatologic disorders: A review.Hepatitis C virus and non-Hodgkin's lymphomas: A minireview.Genetic subclonal complexity and miR125a-5p down-regulation identify a subset of patients with inferior outcome in low-risk CLL patients.HCV and lymphoproliferation.MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer.Hepatitis C virus and diffuse large B-cell lymphoma: Pathogenesis, behavior and treatmentNon-Hodgkin lymphoma and hepatitis C: where we are and what next?Virus-driven autoimmunity and lymphoproliferation: the example of HCV infection.Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi.Cryoglobulin Test and Cryoglobulinemia Hepatitis C-Virus Related.From the pathogenesis to the cure of indolent B-cell lymphoproliferative disorders associated with hepatitis C virus infection: which role for direct-acting antivirals?Hepatitis C viral infection increases the risk of lymphoid-neoplasms: A population-based cohort study.HCV-induced miR146a controls SOCS1/STAT3 and cytokine expression in monocytes to promote regulatory T-cell development.The anti-lymphoma activity of antiviral therapy in HCV-associated B-cell non-Hodgkin lymphomas: a meta-analysis.Deregulation of microRNA expression in peripheral blood mononuclear cells from patients with HCV-related malignancies.HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells.Predictive value of microRNAs as novel biomarkers in detection of lymphoma.MicroRNA as potential biomarker in HCV-associated diffuse large B-cell lymphoma.Unusual Course of Splenic Marginal Zone Lymphoma.Splenic marginal zone lymphoma: comprehensive analysis of gene expression and miRNA profiling.Sofosbuvir–daclatasvir improves hepatitis C virus–induced mixed cryoglobulinemia: Upper Egypt experience.
P2860
Q26746573-B3F5FFAE-E013-4272-954D-6CB28DBB87D1Q26750997-982240A4-4484-406A-B9F7-08E562E0D725Q26801181-60FD60CC-310A-4D5C-A5C3-11FA81F963ABQ26992142-F72A0521-4A8E-4760-A5A0-BC278FAEBF9CQ27010231-5BEF3536-B8AA-46AD-B9BD-A23444A9242EQ27015778-DF2AF097-9EE2-46F3-A1C4-818A7B552842Q28080160-6C65B5CF-3879-4E4B-B6DE-C345E24995DBQ30238653-433AEE48-0238-4FB6-9311-E2777F0E8389Q34163429-AE4F3D88-2C34-472F-9CE1-84A880C67B4BQ34302987-E0F2A358-CA68-4C07-B8C0-CD9FA517EBD3Q34427855-8AF786AE-67DC-4931-B788-AA0A5EE8AD48Q34708468-88EAEAB7-64B5-4012-8F23-E44F7DA85554Q35126362-614D1F4B-EF1B-414A-A09D-575D44C195ABQ36199986-A34EFDA4-3DD9-4BB4-9894-8ED93D7945BEQ36203511-FD6D934E-0FE6-4282-9629-031442D3E4D8Q36715896-F61955E2-BF88-43E9-8289-17EE4A88F52CQ37057240-D22E75BF-83CC-4919-8E43-DA27A56EAF41Q37151661-DA979CA5-5A2C-49BB-929D-D711D0B0C630Q37408923-1331D7C5-C416-4645-8726-717F49B7FCE5Q37610871-D4C43D70-9D81-4216-89AE-27FC28A059D8Q37610899-EF41853F-2ABE-42EB-B6E1-3A8AFFC844FAQ37649648-E6B5498E-5E10-433D-8909-743D2291FFC8Q38031228-E680CDF5-CC3C-4166-A03C-67FB07899FCBQ38095501-8883EF69-4A52-4250-8BD3-7884BF0C332EQ38244519-A2179BE3-4945-4107-A3DD-B32023BBF654Q38255923-674E6A82-F7A6-4902-94E6-939164E946ABQ38298448-CC7E6E12-F711-49BD-A90A-26D4230709F8Q38878814-C3A5CD37-A158-47CB-B1CC-227460931160Q39094313-79406335-7502-4034-87B8-240B08251A4BQ40135838-E6CC866D-04FB-4860-83D5-29773F3ECBEEQ40216845-320D3A2C-0B30-4644-8C5B-0D5B5C0EE96AQ40745016-43A84171-49F3-4AA1-8680-DA859BC5919AQ40774061-C8146074-0F7D-4E90-A8A5-9EE6CD7C268DQ41053182-731923F9-A672-4349-BF6C-AAA6B8DA5040Q41862856-BD2B27A4-10BB-439E-8426-B3CDA05A901AQ41986451-48C8DE0F-A697-4A82-A8A2-0A0CBAD7FB08Q42213358-7BF00CF3-BEFF-4845-B984-6216D01F9459Q47153921-87DBA736-82BA-405B-A32F-C4EDCCEA6ECFQ54271169-D2EED79D-C56C-4AD3-8D68-FAAF11FA5353Q55449137-19620B1B-3651-48CD-9E8E-8C76E80E5ECF
P2860
Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Dysregulation of global microR ...... c hepatitis C virus infection.
@ast
Dysregulation of global microR ...... c hepatitis C virus infection.
@en
Dysregulation of global microR ...... c hepatitis C virus infection.
@nl
type
label
Dysregulation of global microR ...... c hepatitis C virus infection.
@ast
Dysregulation of global microR ...... c hepatitis C virus infection.
@en
Dysregulation of global microR ...... c hepatitis C virus infection.
@nl
prefLabel
Dysregulation of global microR ...... c hepatitis C virus infection.
@ast
Dysregulation of global microR ...... c hepatitis C virus infection.
@en
Dysregulation of global microR ...... c hepatitis C virus infection.
@nl
P2093
P2860
P50
P356
P1433
P1476
Dysregulation of global microR ...... ic hepatitis C virus infection
@en
P2093
J Peveling-Oberhag
M-L Hansmann
S Hartmann
S Rattotti
P2860
P2888
P304
P356
10.1038/LEU.2012.29
P577
2012-02-06T00:00:00Z
P6179
1017147891